Nutraceutical Excipients Market

Nutraceutical Excipients Market by Functionality (Binders, Fillers & Diluents, Coating Agents, and Flavoring Agents), End Product (Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins), Form (Dry and Liquid), and Region - Global Forecast to 2025

Report Code: FB 6004 Jul, 2020, by marketsandmarkets.com

[258 Pages Report]The global nutraceutical excipients market size is estimated to account for USD 3.4 billion in 2020 and is projected to reach USD 4.9 billion by 2025, at a CAGR of 7.3%. The nutraceutical excipients market is driven by advances in nanotechnology used to impart new functions to excipients and a wide range of applications in the food & beverage and dietary supplements industry. However, the decrease in the returns on R&D investments and high clinical trials and registration restraints the market growth prospects. The high use of excipients with multifunctional properties is witnessed as an emerging trend among the key players along with a rising number of government initiatives and awareness campaigns is expected to create new growth opportunities for the growth of the nutraceutical excipients market.

Nutraceutical Excipients Market

“Impact of COVID-19 on the current market size and forecast.”

COVID-19 pandemic has led multiple operations to cease. The global nutraceutical excipients market is increasingly impacted due to the uncertain circumstances that have occurred worldwide. The effects of COVID-19 primarily affect the supply chain of final products, as well as raw material ingredients of global manufacturers. As its major applications are concentrated in products belonging to dietary supplements, followed by food & beverages, the market is projected to witness a slow-down until the local and national governments do not ease import and export regulations. Overall, this market is dominated by the global players that have manufacturing facilities in certain regions and operations/supply across countries.

The market for nutraceutical excipients in North America is projected to record high growth due to the increase in consumption and concentration of key players in the region. However, post-COVID-19, by the third or fourth quarter of 2020, the market for nutraceutical excipients will witness immense growth due to the high consumption of nutraceuticals in the daily dietary lifestyles of consumers. The North American market is projected to witness a substantial increase in demand, as a result of the rise in awareness pertaining to these health-benefiting supplements, as well as the number of cases and casualties, resulting in high demand for immunity boosters and other supplements. Thus, the growth rate is projected to decline during the ongoing pandemic but will increase two-folds after the projected quarters. 

Market dynamics – Drivers, restraints, opportunities, and challenges

Driver: Advancements in nanotechnology equipped with new features to drive the growth of the nutraceutical excipients market

Nanotechnology-enabled drug delivery systems (NDDS) are used to cater to the issue of drug toxicity. There are two major approaches to use nanotechnology as a drug delivery system (DDS). The first is to reduce the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability, while the second approach is to use some form of nano-carrier for effective delivery of active ingredients. In March 2009, the scientific committee of the European Food Safety Agency published an opinion on nanoscience and nanotechnology regarding food and feed safety. A document offering guidance on how to assess potential risks associated with certain food-related uses of nanotechnology was followed in May 2011, providing practical recommendations to regulators on how to assess applications that use engineered nanomaterials in food additives, enzymes, flavorings, food contact materials, novel foods, food supplements, feed additives, and pesticides.

Poor drug physicochemical properties can be improved by associating the drug with a pharmaceutical carrier. A drug delivery system (DDS) can enhance a drug’s pharmacokinetics and cellular penetration. Moreover, the drug delivery system (DDS) may also address obstacles arising from low drug solubility, degradation, fast clearance rates, nonspecific toxicity, and inability to cross biological barriers. Hence, the use of nanotechnology for improving the functionalities of excipients is also projected to drive the growth of the nutraceutical excipients market during the forecast period. 

Restraint: Decrease in returns on R&D investments and high costs of clinical trials and registration.

Excipients and nutraceutical products are clinically and chemically developed, and hence, require extensive R&D investments, clinical trials, and approvals from respective authorities in different countries/regions. In addition, developing such products is not a short-term activity, as it includes the formulation, trial & testing, and commercializing it into the market. However, high R&D investments do not give equal returns in terms of productivity, as even after successful molecule discovery, the cost of bringing a new nutraceutical product and a new excipient into the market is significantly high. In addition, other players in the market develop alternate and cheaper solutions, amidst the trial and testing procedures of one product or solution by another company, which leads to wastage of time, money, and efforts required to come to the later stages of that product, thereby disrupting the complete process of new product development. At the same time, the risk of failure also remains high. The cost of proving the effectiveness of an excipient through clinical trials is also relatively expensive and can be a major hindrance to the development of novel excipients in the market. 

Opportunity: High use of excipients with multifunctional properties is witnessed as an emerging trend among key players.

Multifunctional excipients are a class of excipients that include pre-processed and co-processed excipients that provide added functionalities to the formulation. For example, Silicified Micro-Crystalline Cellulose is a processed combination of MCC and colloidal silicon dioxide. These functionalities include flowability, compressibility, particle size distribution, shape, and porosity. The term multifunctional excipient is also extended to products that serve multiple roles in the formulation of dietary supplement and functional food & beverage line of products; for example, Ludipress is a co-processed product containing lactose, Kollidon, and Kollidon-CL, which serves the role of DC diluent with binder and disintegrant properties.

The demand for excipients with improved functionalities in the nutraceutical industry remains high, while also minimizing the drawbacks of incorporated excipients. According to the International Pharmaceutical Excipient Council (IPEC), a co-processed excipient is “a combination of two or more compendial or non-compendial excipients designed to physically modify their properties in a manner not achievable by simple physical mixing, and without significant chemical change.”

Excipient manufacturers are primarily focusing on developing newer excipients blends to achieve multi-functionalities, and, in turn, to grow strategically, since old excipients cannot address all the challenges related to nutraceutical formulations and the delivery of active ingredients. Thus, the multi-functionality of excipients helps in catering to the increased demand among industry players by saving on the costs incurred to produce a customized excipient.

Challenge: Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception of dietary supplements as pharmaceutical drugs and their false claims.

The majority of the population is skeptical about the consumption of nutraceutical products, particularly the dietary supplement products. In addition, the increase in unawareness among rural and semi-urban consumers about dietary supplements and the lack of education regarding the same discourages key players from investing. This population contributes to a major share of the non-dietary supplement consuming population in the developing and non-developing countries. In addition, consumers perceive dietary supplements as medical drugs and are apprehensive about incorporating the same in their daily dietary lifestyles. Due to these factors, a number of manufacturers are focusing on developing different formulations of supplements, such as gummies, soft chews, and others, on mitigating the fear of consuming tablets and capsules as nutraceuticals. However, these formulations are still in the early stage of entering the global market. In contrast, tablets and capsules in the nutraceutical market already have a majority share, which hinders the growth of this market.

By form, the dry segment is estimated to account for the largest share in the nutraceutical excipients market in 2020.

The dry form of nutraceutical excipients accounted for a larger market share, as compared to the liquid form. The popularity of the dry form can be attributed to its cost-effectiveness and convenience in multiple applications. An increase in demand for dry beverage mixes with additional nutrients, including customized mixes and consumer preference for fortified beverages are fueling the growth of the dry segment in the nutraceutical excipients market.

The binders segment is estimated to account for the largest share in the nutraceutical excipients market in 2020, by functionality.

Based on functionality, binders accounted for the largest market share in 2019, followed by the fillers & diluents functionality segment. Binder is increasingly being used by dietary supplement manufacturers since these excipients are formulated to act as an adhesive to “bind together” powders, granules, and other dry ingredients to impart the required mechanical strength. Binders can also help in adding volume to low-active dose tablets, resulting in producing effective tablets with appropriate actives by holding the ingredients together. In addition, some binders also act as fillers and diluents in an array of application products, namely magnesium stearate, which is used widely as food and supplement additive. Due to factors such as versatility and vital importance in gaining product efficiency, binders are gaining traction and are witnessing a rise in consumption as an excipient in the nutraceutical industry. 

The segment estimated to account for the largest share in the nutraceutical excipients market in 2020, by end product, is the probiotics segments.

Probiotics are yeast and good bacteria that are beneficial for consumers, as they enhance digestion and gut health, improve immunity, increase nutrient absorption, and lower the chances of food allergies. Probiotic products are offered in different forms, including yogurt and drinks, and supplement forms such as tablets and capsules. However, there are two main challenges to develop a probiotic formulation viable for commercial utilization. The first one is the quality of health attributes that the probiotic organisms can confer, and the second one is the stability of the formulation until the end of its shelf life. Companies are focusing on developing and offering probiotic blend products, which includes APIs (Active Pharmaceutical Ingredient), containing probiotic formulations by using different types of excipients. Among the excipients used in these blends for probiotics formulation, mannitol was found the most suitable, which helped in the enhancement of the shelf life of end-products.

North America dominated the global nutraceutical excipients market in 2019; however, Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

North America accounted for the largest market share in 2019. The nutraceutical excipients market in North America is dominating, owing to the concentration of the global players such as DuPont (US), Kerry (Ireland), Cargill (US), and Ingredion (US). The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions. Other factors contributing to the growth of nutraceutical excipients in North American region include the busy lifestyle of consumers, prevalence of chronic diseases due to hectic lifestyles, and an increase in awareness among consumers regarding the health benefits of nutritional foods, including food supplements, which has driven the demand for functional food products. In addition, the use of technological advancements and new product launches have made excipients available for a wide range of applications in the fortified food & beverage, dietary supplements, and nutraceuticals sectors, which is projected to drive the growth of the market in the region.

The Asia Pacific region is projected to be the fastest-growing market for nutraceutical excipients from 2020 to 2025. The rise in income and purchasing power, rapid growth of the middle-class population, increase in consumer awareness about health & fitness, and rise in consumer demand for nutritional & healthy products provide promising prospects for growth and diversification in the region’s food sectors, such as nutraceuticals. The region is attracting investors for setting up production facilities due to the liberalization of foreign direct investments in the food sector, the ease of availability of raw materials, skilled labor, land, and equipment at a lower cost. Also, the market for nutraceutical excipients in the region is relatively not as mature as the market in the North American region, which further propels the growth prospects for the Asia Pacific region.

Nutraceutical Excipients Market By Region

Key Market Players

This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies in the nutraceutical excipients market.  The key players in the nutraceutical excipients market include The nutraceutical excipients market also consists of key start-up players, which include IMCD (Netherlands), Hilmar Ingredients (US), Innophos Holdings Inc (US), JRS Pharma (Germany), Biogrund GmbH (Germany), Pharma Line Int'l Corp (South Korea), Jigs Chemical (India), Panchamrut Chemicals (India), Azelis Chemical Ltd (Europe), and Daicel Group (Japan).

Scope of the Report

Report Metric

Details

Market size estimation

2018-2025

Base year considered

2019

Forecast period considered

2020–2025

kUnits considered

Value (USD) and Volume (KT)

Segments covered

  • Functionalities
  • Form
  • End product
  • Region

Regions covered

  • North America
  • Europe
  • Asia Pacific
  • South America
  • The Middle East and Africa

Companies studied

  • DuPont (US)
  • BASF SE (Germany)
  • Kerry Group PLC (Ireland)
  • Ingredion Plc (US)
  • Sensient Technologies (US)
  • Associated British Foods (UK)
  • Roquette Freres (France)
  • Meggle Group Wasser (Germany)
  • Cargill Inc (US)
  • Ashland Global Holdings Inc (US)
  • Seppic (France)
  • Shin-Etsu Chemical Co Ltd (Japan)
  • Fuji Chemical Industries Co Ltd (Japan)
  • Pharmatrans Sanaq AG (Switzerland)
  • Pioma Chemicals (India)
  • Gattefosse (India)
  • W.R. Grace & Co (US)
  • Omya (Switzerland)
  • Grain Processing Corp (US)
  • Gangwal Chemicals Pvt Ltd (India)
  • IMCD (Netherlands)
  • Hilmar Ingredients (US)
  • Innophos Holdings Inc (US)
  • JRS Pharma (Germany)
  • Biogrund GmbH (Germany)
  • Pharma Line Int'l Corp (South Korea)
  • Jigs Chemical (India)
  • Panchamrut Chemicals (India)
  • Azelis Chemical Ltd (Europe)
  • Daicel Group (Japan).

Target Audience:

  • Supply-side: Nutraceutical excipients manufacturers, raw material suppliers, importers, and exporters
  • Demand-side: Dietary supplement product manufacturers, fortified foods and beverages product manufacturers, retailers, distributors, and wholesalers.
  • Regulatory side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies
  • Associations and industry bodies: Food and Agriculture Organization (FAO), United States Department of Agriculture (USDA), Environmental Protection Agency (EPA), the Food Safety Council (FSC), European Food Safety Authority (EFSA), Arthritis Foundation, World Health Organization (WHO), All India Food Processing Association (AIFPA), National Center for Biotechnology Information (NCBI), National Library of Medicine (NLM), National Institutes of Health (NIH), Center for Food Safety (CFS), World Bank, and Organization for Economic Co-operation and Development (OECD).

By Functionality:

  • Binders
    • Cellulose
    • Povidone
    • Starch
    • Other binder types
  • Fillers and diluents
  • Disintegrants
  • Coating agents
  • Flavoring agents
  • Lubricants
  • Other functionalities

By Form:

  • Dry
  • Liquid

By End product:

  • Protein & amino acids
  • Omega-3 fatty acids
  • Vitamins
  • Minerals
  • Prebiotics
  • Probiotics
  • Other end products

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • The Middle East and Africa

Recent Developments

  • In June 2020, IMCD announces the extension of its partnership with DuPont Health and nutrition (US). This development will benefit both the companies in strengthening their footprints in Kenya, Uganda, and Egypt by offering a combined line of products to distinct industry users.  
  • In March 2020, Azelis Chemical Ltd signed an agreement with CosBond (China), a specialty chemical and food ingredient distributor, to acquire it. This development helped Azelis strengthen its distribution network in the Chinese market with the expertise of CosBond’s existing network channel and reach.
  • In December 2019, DuPont signed an agreement to merge its Nutrition & Biosciences business with IFF (US). The development details include valuing the combined company at USD 45.4 Billion. DuPont owned a majority of the shares, which is 55.4% and the remaining 44.6% by IFF, which is unanimously approved. This development is expected to help the company broaden its capabilities offering nutritional ingredients and solutions to global consumers.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
           1.3.1 MARKET SEGMENTATION
                 FIGURE 1 REGIONS COVERED
    1.4 PERIODIZATION CONSIDERED
    1.5 CURRENCY CONSIDERED
        TABLE 1 USD EXCHANGE RATES, 2015-2019
    1.6 UNITS CONSIDERED
    1.7 STAKEHOLDERS
    1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
        FIGURE 2 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key Data from Secondary Sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of Primaries
    2.2 MARKET SIZE ESTIMATION
    2.3 DATA TRIANGULATION
        FIGURE 3 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS/HYPOTHESIS FOR THE STUDY
    2.5 LIMITATIONS OF THE STUDY
    2.6 MARKET SCENARIOS CONSIDERED DUE TO THE IMPACT OF  COVID-19
           2.6.1 SCENARIO-BASED MODELLING
    2.7 COVID-19 HEALTH ASSESSMENT
        FIGURE 4 COVID-19: THE GLOBAL PROPAGATION
        FIGURE 5 COVID-19 PROPAGATION: SELECT COUNTRIES
    2.8 COVID-19 ECONOMIC ASSESSMENT
        FIGURE 6 REVISED GDP FORECASTS FOR SELECT G20 COUNTRIES IN 2020
           2.8.1 COVID-19 IMPACT ON THE ECONOMY-SCENARIO ASSESSMENT
                 FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY
                 FIGURE 8 SCENARIOS IN TERMS OF RECOVERY OF THE GLOBAL ECONOMY
 
3 EXECUTIVE SUMMARY (Page No. - 48)
  FIGURE 9 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2020 VS. 2025 (USD MILLION)
  FIGURE 10 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2020 VS. 2025 (USD MILLION)
  FIGURE 11 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2020 VS. 2025 (USD MILLION)
  FIGURE 12 NUTRACEUTICAL EXCIPIENTS MARKET SHARE & GROWTH (VALUE), BY REGION
  FIGURE 13 IMPACT OF COVID-19 ON THE NUTRACEUTICAL EXCIPIENTS MARKET,  BY SCENARIOS, 2020-2021

4 PREMIUM INSIGHTS (Page No. - 53)
    4.1 ATTRACTIVE OPPORTUNITIES IN THE NUTRACEUTICAL EXCIPIENTS MARKET
        FIGURE 14 NUTRACEUTICAL EXCIPIENTS: AN EMERGING MARKET WITH IMMENSE GROWTH POTENTIAL
    4.2 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
        FIGURE 15 ASIA PACIFIC TO GROW AT THE HIGHEST RATE IN THE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2020 TO 2025
    4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
        FIGURE 16 THE BINDERS SEGMENT, BY FUNCTIONALITY, IS ESTIMATED TO DOMINATE THE MARKET IN 2020 (VALUE)
    4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM
        FIGURE 17 THE DRY SEGMENT IS PROJECTED TO DOMINATE THE MARKET FROM  2020 TO 2025 (USD MILLION)
    4.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
        FIGURE 18 THE PROBIOTICS SEGMENT IS PROJECTED TO DOMINATE THE MARKET FROM 2020 TO 2025 (USD MILLION)
    4.6 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET,  BY FUNCTIONALITY AND COUNTRY
        FIGURE 19 THE BINDERS SEGMENT, BY FUNCTIONALITY, ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2019
        FIGURE 20 THE US, FOLLOWED BY JAPAN, OCCUPIED A MAJOR SHARE IN THE GLOBAL MARKET IN 2019
        FIGURE 21 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
        FIGURE 22 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
        FIGURE 23 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 24 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increased focus on preventive care is encouraging investments in products/solutions, which, in turn, is driving the demand for nutraceutical excipients
                            FIGURE 25 NUMBER OF DEATHS CAUSED GLOBALLY, BY DISEASE, IN 2017 (MILLION)
                            FIGURE 26 POPULATION AGED 60 YEARS OR ABOVE, BY REGION
                    5.2.1.2 Advancements in nanotechnology equipped with new features to drive the growth of the nutraceutical excipients market
                    5.2.1.3 Rise in demand for fortified food products due to the increase in health consciousness among consumers
                            FIGURE 27 PERCEIVED HEALTHFULNESS OF NUTRIENTS IN FOOD
                    5.2.1.4 Introduction of mandates on food fortification by government organizations
           5.2.2 RESTRAINTS
                    5.2.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High use of excipients with multifunctional properties is witnessed as an emerging trend among key players
           5.2.4 CHALLENGES
                    5.2.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception on dietary supplements as pharmaceutical drugs and their false claims
    5.3 ECOSYSTEM/ MARKET MAP
        FIGURE 28 FOOD & BEVERAGE ADDITIVES: ECOSYSTEM VIEW
        FIGURE 29 FOOD & BEVERAGE ADDITIVES: MARKET MAP
        FIGURE 30 NUTRACEUTICALS AND DIETARY SUPPLEMENTS: ECOSYSTEM VIEW
        FIGURE 31 NUTRACEUTICALS AND DIETARY SUPPLEMENTS: MARKET MAP
    5.4 YC & YCC SHIFT
        FIGURE 32 YC & YCC SHIFT FOR THE NUTRACEUTICAL EXCIPIENTS MARKET
    5.5 VALUE CHAIN ANALYSIS
        FIGURE 33 NUTRACEUTICAL EXCIPIENTS - VALUE CHAIN

6 PATENT ANALYSIS (Page No. - 68)
  FIGURE 34 GEOGRAPHICAL ANALYSIS: PATENT APPROVAL FOR THE NUTRACEUTICAL EXCIPIENTS MARKET, 2015-2020
  TABLE 2 LIST OF IMPORTANT PATENTS FOR NUTRACEUTICAL EXCIPIENTS, 2019-2020?

7 ORGANIZATIONS/ REGULATIONS GOVERNING THE NUTRACEUTICAL EXCIPIENTS AND NUTRACEUTICAL PRODUCTS MARKET (Page No. - 71)
    7.1 INTRODUCTION
        TABLE 3 DEFINITIONS AND REGULATIONS FOR NUTRACEUTICALS AROUND THE WORLD
    7.2 NORTH AMERICA
           7.2.1 CANADA
           7.2.2 US
           7.2.3 MEXICO
    7.3 EUROPEAN UNION (EU)
           7.3.1 FRANCE
           7.3.2 RUSSIA
           7.3.3 SPAIN
    7.4 ASIA PACIFIC
           7.4.1 JAPAN
           7.4.2 CHINA
           7.4.3 INDIA
           7.4.4 AUSTRALIA & NEW ZEALAND
    7.5 SOUTH AMERICA
           7.5.1 BRAZIL
           7.5.2 ARGENTINA
    7.6 MIDDLE EAST & AFRICA
           7.6.1 ISRAEL

8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT (Page No. - 76)
    8.1 INTRODUCTION
        FIGURE 35 NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY END PRODUCT, 2020 VS 2025
        TABLE 4 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
        TABLE 5 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT, 2018-2025 (KT)
        TABLE 6 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
        TABLE 7 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
        TABLE 8 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
    8.2 PROBIOTICS
           8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY ENHANCING PRODUCTS POST-COVID-19 TO DRIVE THE MARKET GROWTH FOR PROBIOTICS IN THE COMING YEARS
                 TABLE 9 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PROBIOTICS, BY REGION,  2018-2025 (USD MILLION)
                 TABLE 10 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PROBIOTICS, BY REGION, 2018-2025 (KT)
    8.3 PREBIOTICS
           8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULT IN ACIDITY AND INFLAMMATORY ISSUES, WHICH ENCOURAGES THE CONSUMPTION OF PREBIOTICS AS A PREVENTIVE MEASURE
                 TABLE 11 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PREBIOTICS, BY REGION,  2018-2025 (USD MILLION)
                 TABLE 12 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PREBIOTICS, BY REGION, 2018-2025 (KT)
    8.4 PROTEINS & AMINO ACIDS
           8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG THE YOUTH POPULATION TO DRIVE THE GROWTH OF THE NUTRACEUTICAL EXCIPIENTS MARKET
                 TABLE 13 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PROTEINS & AMINO ACIDS, BY REGION, 2018-2025 (USD MILLION)
                 TABLE 14 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN PROTEINS & AMINO ACIDS, BY REGION, 2018-2025 (KT)
    8.5 VITAMINS
           8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS LEAD TO INCREASED USE IN DAILY DIETS, WHICH, IN TURN, DRIVES THE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
                 TABLE 15 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN VITAMINS, BY REGION,  2018-2025 (USD MILLION)
                 TABLE 16 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN VITAMINS, BY REGION, 2018-2025 (KT)
    8.6 MINERALS
           8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART IN THE HUMAN BODY TO DRIVE THE GROWTH OF THE NUTRACEUTICAL EXCIPIENTS MARKET
                 TABLE 17 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN MINERALS, BY REGION,  2018-2025 (USD MILLION)
                 TABLE 18 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN MINERALS, BY REGION, 2018-2025 (KT)
    8.7 OMEGA-3 FATTY ACIDS
           8.7.1 MULTIPLE BENEFITS OFFERED BY OMEGA-3 FATTY ACIDS TO HUMAN HEALTH IS ENCOURAGING ITS CONSUMPTION ACROSS REGIONS
                 TABLE 19 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN OMEGA-3 FATTY ACIDS,  BY REGION, 2018-2025 (USD MILLION)
                 TABLE 20 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN OMEGA-3 FATTY ACIDS, BY REGION,  2018-2025 (KT)
    8.8 OTHER END PRODUCTS
           8.8.1 GROWING AWARENESS PERTAINING TO HEALTH-BENEFITTING DIETARY SUPPLEMENTS OFFERS ADDITIONAL NUTRIENTS, WHICH DRIVE THE GROWTH OF THE MARKET
                 TABLE 21 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN OTHER END PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
                 TABLE 22 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN OTHER END PRODUCTS,  BY REGION, 2018-2025 (KT)

9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM (Page No. - 90)
    9.1 INTRODUCTION
        FIGURE 36 NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY FORM, 2020 VS 2025
        TABLE 23 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
        TABLE 24 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (KT)
        TABLE 25 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
        TABLE 26 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
        TABLE 27 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
    9.2 DRY
           9.2.1 MULTIFUNCTIONAL PROPERTIES OF DRY NUTRACEUTICAL EXCIPIENTS AND THEIR COST-EFFECTIVENESS TO DRIVE THE GROWTH OF THIS SEGMENT IN THE GLOBAL MARKET
                 TABLE 28 DRY NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
                 TABLE 29 DRY NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (KT)
    9.3 LIQUID
           9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN ITS FORMULATIONS TO DRIVE THE GROWTH OF THIS SEGMENT
                 TABLE 30 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION,  2018-2025 (USD MILLION)
                 TABLE 31 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (KT)

10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY (Page No. - 96)
     10.1 INTRODUCTION
          FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTIONALITY,  2020 VS 2025
          TABLE 32 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
          TABLE 33 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (KT)
          TABLE 34 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
          TABLE 35 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
          TABLE 36 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
     10.2 BINDERS
            10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE THE GROWTH OF THE GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET
                   TABLE 37 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 38 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY REGION, 2018-2025 (KT)
                   TABLE 39 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY,  2018-2025 (USD MILLION)
                   TABLE 40 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY,  2018-2025 (KT)
            10.2.2 CELLULOSE
                   TABLE 41 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR CELLULOSE, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 42 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR CELLULOSE, BY REGION,  2018-2025 (KT)
            10.2.3 POVIDONE
                   TABLE 43 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR POVIDONE, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 44 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR POVIDONE, BY REGION, 2018-2025 (KT)
            10.2.4 STARCH
                   TABLE 45 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR STARCH, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 46 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR STARCH, BY REGION,  2018-2025 (KT)
            10.2.5 OTHER BINDER TYPES
                   TABLE 47 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR OTHER BINDER TYPES, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 48 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR OTHER BINDER TYPES, BY REGION, 2018-2025 (KT)
     10.3 FILLERS & DILUENTS
            10.3.1 USE OF ACTIVE INGREDIENTS IN A NUTRACEUTICAL PRODUCT ENCOURAGE THE USE OF FILLERS AND DILUENTS AS EXCIPIENTS IN THE GLOBAL MARKET
                   TABLE 49 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR FILLERS & DILUENTS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR FILLERS & DILUENTS, BY REGION,  2018-2025 (KT)
     10.4 DISINTEGRANTS
            10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN THE FORM OF ORAL DOSAGES OR TABLETS TO DRIVE THE GROWTH OF THE DISINTEGRANTS SEGMENT
                   TABLE 51 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR DISINTEGRANTS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 52 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR DISINTEGRANTS, BY REGION,  2018-2025 (KT)
     10.5 COATING AGENTS
            10.5.1 INNOVATIONS IN COATING AGENTS OF EXCIPIENT PRODUCTS AND THEIR APPLICATIONS IN DIETARY SUPPLEMENT PRODUCTS TO DRIVE THE MARKET GROWTH
                   TABLE 53 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR COATING AGENTS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 54 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR COATING AGENTS, BY REGION,  2018-2025 (KT)
     10.6 FLAVORING AGENTS
            10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE THE GROWTH OF THE FLAVORING AGENTS SEGMENT
                   TABLE 55 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR FLAVORING AGENTS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 56 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR FLAVORING AGENTS, BY REGION,  2018-2025 (KT)
     10.7 LUBRICANTS
            10.7.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING THE FORMULATION DURING THE PRODUCTION PROCESS INTACT DRIVES THE GROWTH OF THE LUBRICANTS SEGMENT
                   TABLE 57 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR LUBRICANTS, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 58 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR LUBRICANTS, BY REGION,  2018-2025 (KT)
     10.8 OTHER FUNCTIONALITIES
            10.8.1 INCREASE IN HEALTH BENEFITS OF NUTRACEUTICAL EXCIPIENTS AND USE IN DIETARY SUPPLEMENTS TO DRIVE THE GROWTH OF THE OTHER FUNCTIONALITIES SEGMENT
                   TABLE 59 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR OTHER FUNCTIONALITIES, BY REGION,  2018-2025 (USD MILLION)
                   TABLE 60 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR OTHER FUNCTIONALITIES, BY REGION,  2018-2025 (KT)

11 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION (Page No. - 115)
     11.1 INTRODUCTION
          FIGURE 38 GEOGRAPHIC SNAPSHOT (2020-2025): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOTSPOTS
          TABLE 61 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
          TABLE 62 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (KT)
          TABLE 63 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
          TABLE 64 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
          TABLE 65 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 39 NORTH AMERICA: MARKET SNAPSHOT
          TABLE 66 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (USD MILLION)
          TABLE 67 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (KT)
          TABLE 68 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018 -2025 (USD MILLION)
          TABLE 69 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (KT)
          TABLE 70 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
          TABLE 71 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
          TABLE 72 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
          TABLE 73 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (KT)
          TABLE 74 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
          TABLE 75 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (KT)
            11.2.1 US
                     11.2.1.1 High concentration of key players in the country and increase in preventive healthcare trends to drive the growth of the nutraceutical excipients market in the coming years
                              TABLE 76 US: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 77 US: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.2.2 CANADA
                     11.2.2.1 Manufacturers offer functionality-specific products for consumers that prefer dietary supplements, which widens their growth prospects
                              TABLE 78 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 79 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.2.3 MEXICO
                     11.2.3.1 Increase in foreign direct investments and rise in consumer awareness regarding healthier lifestyles associated with dietary supplements to drive the market growth for nutraceutical excipients
                              TABLE 80 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 81 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
     11.3 EUROPE
          TABLE 82 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 83 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (KT)
          TABLE 84 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
          TABLE 85 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (KT)
          TABLE 86 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
          TABLE 87 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (KT)
          TABLE 88 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
          TABLE 89 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (KT)
          TABLE 90 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
          TABLE 91 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (KT)
            11.3.1 GERMANY
                     11.3.1.1 Increase in innovations in food products to cater to the demands of consumers and key players in the market to drive the market growth in the coming years
                              TABLE 92 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 93 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.3.2 FRANCE
                     11.3.2.1 Innovations in product formulations to cater to the increased consumer demands drives the market growth
                              TABLE 94 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 95 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.3.3 UK
                     11.3.3.1 Growth of the functional/fortified food & beverage industry in the country to drive the demand for nutraceutical excipients
                              TABLE 96 UK: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
                              TABLE 97 UK: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.3.4 ITALY
                     11.3.4.1 Rise in the growth of the food and beverage industry and the number of health-conscious consumers to drive the demand for nutraceutical excipients in the country
                              TABLE 98 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 99 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.3.5 SPAIN
                     11.3.5.1 Increase in initiatives taken by local and national agencies for consumer affairs regarding the safety and benefits of food products to encourage the consumption of nutraceutical excipients
                              TABLE 100 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 101 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.3.6 REST OF EUROPE
                     11.3.6.1 Increase in functionalities of excipients drives the market growth but stringent registration processes continues to hinder it
                              TABLE 102 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 103 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
     11.4 ASIA PACIFIC
          FIGURE 40 ASIA PACIFIC: MARKET SNAPSHOT
          TABLE 104 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (USD MILLION)
          TABLE 105 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (KT)
          TABLE 106 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
          TABLE 107 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (KT)
          TABLE 108 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
          TABLE 109 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (KT)
          TABLE 110 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
          TABLE 111 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (KT)
          TABLE 112 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
          TABLE 113 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (KT)
            11.4.1 CHINA
                     11.4.1.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products to drive the demand
                              TABLE 114 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 115 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.4.2 JAPAN
                     11.4.2.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive the growth of the nutraceutical excipients market
                              TABLE 116 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 117 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.4.3 INDIA
                     11.4.3.1 Rise in awareness about the health benefits provided by dietary supplements and the increase in occurrences of chronic diseases to drive the market growth in the country
                              TABLE 118 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 119 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.4.4 AUSTRALIA & NEW ZEALAND
                     11.4.4.1 High spending capacity on nutritional products and an increase in disposable incomes to drive the market growth in the coming years
                              TABLE 120 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
                              TABLE 121 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.4.5 REST OF ASIA PACIFIC
                     11.4.5.1 Government initiatives and changing consumer preferences for health-enriching foods to encourage the growth of the nutraceutical excipients market in these countries
                              TABLE 122 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
                              TABLE 123 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
     11.5 SOUTH AMERICA
          TABLE 124 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (USD MILLION)
          TABLE 125 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY,  2018-2025 (KT)
          TABLE 126 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
          TABLE 127 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (KT)
          TABLE 128 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
          TABLE 129 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (KT)
          TABLE 130 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
          TABLE 131 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (KT)
          TABLE 132 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
          TABLE 133 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (KT)
            11.5.1 BRAZIL
                     11.5.1.1 Growing awareness regarding the benefits of functional foods, sports nutrition, and dietary supplements benefits for preventive healthcare to drive the demand for nutraceutical excipients
                              TABLE 134 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 135 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.5.2 ARGENTINA
                     11.5.2.1 Imbalance in nutrition intake leads to several diseases, which, in turn, drives the growth of the nutraceutical excipients market
                              TABLE 136 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 137 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
            11.5.3 REST OF SOUTH AMERICA
                     11.5.3.1 Government initiatives promoting the adoption of healthier dietary lifestyles to drive the market growth for nutraceutical excipients in the coming years
                              TABLE 138 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE,  BY FUNCTIONALITY, 2018-2025 (USD MILLION)
                              TABLE 139 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA
          TABLE 140 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION,  2018-2025 (USD MILLION)
          TABLE 141 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION,  2018-2025 (KT)
          TABLE 142 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
          TABLE 143 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (KT)
          TABLE 144 MIDDLE EAST AND AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
          TABLE 145 MIDDLE EAST AND AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS,  BY SUBFUNCTIONALITY, 2018-2025 (KT)
          TABLE 146 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (USD MILLION)
          TABLE 147 MIDDLE EAST & AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT,  2018-2025 (KT)
          TABLE 148 MIDDLE EAST AND AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
          TABLE 149 MIDDLE EAST AND AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (KT)
            11.6.1 MIDDLE EAST
                     11.6.1.1 Rise in obesity and other health-related concerns to drive the growth of the nutraceutical excipients market
                              TABLE 150 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 151 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)
            11.6.2 AFRICA
                     11.6.2.1 Intra-African trade policies and investments in the country by global nutraceutical players to drive the market growth
                              TABLE 152 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY,  2018-2025 (USD MILLION)
                              TABLE 153 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM,  2018-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 178)
     12.1 OVERVIEW
     12.2 MARKET EVALUATION FRAMEWORK
          FIGURE 41 MARKET EVALUATION FRAMEWORK: 2017 TO 2020
     12.3 COMPETITIVE LEADERSHIP MAPPING
            12.3.1 STARS
            12.3.2 EMERGING LEADER
            12.3.3 PERVASIVE
            12.3.4 EMERGING COMPANIES
                   FIGURE 42 NUTRACEUTICAL EXCIPIENTS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2020 (TOP 20)
     12.4 START-UP MICROQUADRANT
            12.4.1 PROGRESSIVE COMPANIES
            12.4.2 RESPONSIVE COMPANIES
            12.4.3 DYNAMIC COMPANIES
            12.4.4 STARTING BLOCKS
                   FIGURE 43 NUTRACEUTICAL EXCIPIENTS MARKET (GLOBAL) START-UP COMPETITIVE LEADERSHIP MAPPING, 2020 (TOP 10)
                   FIGURE 44 KEY DEVELOPMENTS OF LEADING PLAYERS IN THE NUTRACEUTICAL EXCIPIENTS MARKET, 2017-2020
     12.5 MARKET SHARE ANALYSIS, 2020
          FIGURE 45 CARGILL DOMINATED THE NUTRACEUTICAL EXCIPIENTS MARKET IN 2019
     12.6 COMPETITIVE SCENARIO
            12.6.1 NEW PRODUCT LAUNCHES
                   TABLE 154 NEW PRODUCT LAUNCHES
            12.6.2 EXPANSIONS & INVESTMENTS
                   TABLE 155 EXPANSIONS & INVESTMENTS
            12.6.3 MERGERS & ACQUISITIONS
                   TABLE 156 MERGERS & ACQUISITIONS
            12.6.4 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS
                   TABLE 157 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS
 
13 COMPANY PROFILES (Page No. - 193)
(Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view)*
     13.1 DUPONT
          FIGURE 46 DUPONT: COMPANY SNAPSHOT
     13.2 KERRY GROUP PLC
          FIGURE 47 KERRY GROUP PLC: COMPANY SNAPSHOT
     13.3 INGREDION INC
          FIGURE 48 INGREDION INC: COMPANY SNAPSHOT
     13.4 SENSIENT TECHNOLOGIES CORPORATION
          FIGURE 49 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
     13.5 ASSOCIATED BRITISH FOODS (ABF) PLC
          FIGURE 50 ASSOCIATED BRITISH FOOD (ABF) PLC: COMPANY SNAPSHOT
     13.6 BASF SE
          FIGURE 51 BASF SE: COMPANY SNAPSHOT
     13.7 ROQUETTE FRERES
          FIGURE 52 ROUQUETTE FRERES: COMPANY SNAPSHOT
     13.8 MEGGLE GROUP WASSERBURG
     13.9 CARGILL INCORPORATED
          FIGURE 53 CARGILL INCORPORATED: COMPANY SNAPSHOT
     13.10 ASHLAND GLOBAL HOLDINGS INC
          FIGURE 54 ASHLAND GLOBAL HOLDINGS INC: COMPANY SNAPSHOT

*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.

14 COMPANY PROFILES (START-UPS) (Page No. - 226)
     14.1 HILMAR INGREDIENTS
     14.2 IMCD
          FIGURE 55 IMCD: COMPANY SNAPSHOT
     14.3 INNOPHOS HOLDINGS INC
          FIGURE 56 INNOPHOS HOLDINGS INC: COMPANY SNAPSHOT
     14.4 JRS PHARMA
     14.5 BIOGRUND GMBH
     14.6 PHARMA LINE INT'L CORP
     14.7 AZELIS CHEMICAL LTD
     14.8 DAICEL GROUP
          FIGURE 57 DAICEL GROUP: COMPANY SNAPSHOT
     14.9 JIGS CHEMICAL LTD
     14.1 PANCHAMRUT CHEMICALS

15 LIST OF COMPANIES IN  NUTRACEUTICAL MARKET ECOSYSTEM (Page No. - 250)
     15.1 NUTRACEUTICAL INGREDIENT MANUFACTURERS
     15.2 NUTRACEUTICAL FOOD & BEVERAGE MANUFACTURERS
     15.3 DIETARY SUPPLEMENTS MANUFACTURERS

16 APPENDIX (Page No. - 251)
     16.1 DISCUSSION GUIDE
     16.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
     16.3 AVAILABLE CUSTOMIZATIONS
     16.4 RELATED REPORTS
     16.5 AUTHOR DETAILS

The study involved four major activities for estimating the global market size of nutraceutical excipients. Exhaustive secondary research was conducted to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of the segments and sub-segments. 

Secondary Research

In the secondary research process, various sources such as the Food and Agriculture Organization (FAO), United States Department of Agriculture (USDA), European Food Safety Authority (EFSA), World Health Organization (WHO), All India Food Processing Association (AIFPA), Environmental Protection Agency (EPA), the Food Safety Council (FSC), National Center for Biotechnology Information (NCBI), National Library of Medicine (NLM), National Institutes of Health (NIH), Center for Food Safety (CFS), World Bank, and Organization for Economic Co-operation and Development (OECD), were referred to, to identify and collect information for this study. The secondary sources also include clinical studies & journals, press releases, investor presentations of companies, white papers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases. 

Secondary research was mainly conducted to obtain key information about the industry’s supply chain, the total pool of key players, market classification & segmentation according to the industry trends to the bottom-most level, and geographical markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The market comprises several stakeholders in the supply chain, which include raw material suppliers and nutraceutical excipient manufacturers. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewees from the supply-side include exogenous nutraceutical excipient manufacturers. The primary sources from the demand-side include distributors, wholesalers, importers, and exporters of nutraceutical excipients. 

Nutraceutical Excipients Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical excipients market. These approaches were also used extensively to estimate the size of various sub-segments in the market for the base year (2019) in terms of value. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets were identified through extensive secondary research.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • The industry’s value chain and market size, in terms of value, were determined through primary and secondary research.
  • The research included the study of reports, reviews, and newsletters of top market players, along with the extensive interviews for opinions from leaders such as CEOs, directors, and marketing executives.

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. In addition, the market size was validated using both the top-down and bottom-up approaches, which was then verified through primary interviews. Thus, there are three approaches; first is the top-down approach, second is the bottom-up approach, and the third approach includes learning and verification of collected information through expert interviews. Only when the values derived through these three approaches match is the data assumed to be correct.

Report Objectives

MARKET INTELLIGENCE

  • Determining and projecting the size of the nutraceutical excipients market, with respect to functionality, form, end product, and regional markets, over five years, ranging from 2020 to 2025
  • Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • Providing detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • Analyzing the micromarkets, with respect to individual growth trends, prospects, and their contribution to the total market

COMPETITIVE INTELLIGENCE

  • Identifying and profiling the key market players in the nutraceutical excipients market
  • Providing a comparative analysis of market leaders based on the following:
  • Product offerings
  • Business strategies
  • Strengths and weaknesses
  • Key financials
  • Understanding the competitive landscape and identifying the major growth strategies adopted by players across the key regions
  • Analyzing the value chain and products across the key regions and their impact on the prominent market players
  • Providing insights into key product innovations and investments in the nutraceutical excipients market 

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to client-specific needs. The following customization options are available for the report:

GEOGRAPHIC ANALYSIS

  • Further breakdown of the Rest of Asia Pacific nutraceutical excipients market into South Korea and Southeast Asian countries such as Indonesia, Vietnam, the Philippines, Malaysia, Singapore, and Thailand.
  • Further breakdown of the Rest of Europe nutraceutical excipients market into Russia, Poland, Switzerland, the Netherlands, and other EU and non-EU countries.
  • Further breakdown of the Rest of South America nutraceutical excipients market into Chile, Colombia, Peru, Venezuela, Ecuador, Guatemala, and the Dominican Republic. 

SEGMENTAL ANALYSIS

  • Further breakdown of the binder segment in the nutraceutical excipients market into cellulose, povidone, starch, and other binders.
  • Further breakdown of the other functionalities in the nutraceutical excipients market into preservatives, colorants, and antioxidants.
  • Further breakdown of the other end products in the nutraceutical excipients market fibers, carbohydrates, and plant extracts.

COMPANY INFORMATION

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Nutraceutical Excipients Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Nutraceutical Excipients Market

Request For Special Pricing
Report Code
FB 6004
Published ON
Jul, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Excipients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home